Correlation Between Enveric Biosciences and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and Protalix Biotherapeutics, you can compare the effects of market volatilities on Enveric Biosciences and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Protalix Biotherapeutics.
Diversification Opportunities for Enveric Biosciences and Protalix Biotherapeutics
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Enveric and Protalix is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Enveric Biosciences and Protalix Biotherapeutics
Given the investment horizon of 90 days Enveric Biosciences is expected to under-perform the Protalix Biotherapeutics. In addition to that, Enveric Biosciences is 2.38 times more volatile than Protalix Biotherapeutics. It trades about -0.03 of its total potential returns per unit of risk. Protalix Biotherapeutics is currently generating about 0.05 per unit of volatility. If you would invest 159.00 in Protalix Biotherapeutics on November 9, 2024 and sell it today you would earn a total of 110.00 from holding Protalix Biotherapeutics or generate 69.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enveric Biosciences vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Enveric Biosciences |
| Protalix Biotherapeutics |
Enveric Biosciences and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enveric Biosciences and Protalix Biotherapeutics
The main advantage of trading using opposite Enveric Biosciences and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |